Skip to Main Content

Omnipod 5, an AID system, Approved in Ages 2 and Older

September 11, 2022
CGM Technology and Digital Health
Article / Publication

The US Food and Drug Administration (FDA) approved the Omni Pod 5 tubeless insulin pump technology for individuals aged 2 years and older with type 1 diabetes (T1D). Omnipod 5 is the first tubeless, wearable automated insulin delivery (AID) system that integrates with the Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system and a compatible smartphone to automatically adjust insulin and help protect against both hyper- and hypoglycemia.

Learn More
Share: